41 results on '"Barr, Martin P."'
Search Results
2. Genomic Landscape of Non-Small Cell Lung Cancer in the Republic of Ireland
3. Prognostic value and immune regulatory role of dynamin 1-like in lung adenocarcinoma
4. European Epidemiology of Pleural Mesothelioma—Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma Database
5. Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in EGFR-Mutated NSCLC
6. Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses
7. CircP4HB regulates ferroptosis via SLC7A11-mediated glutathione synthesis in lung adenocarcinoma
8. Cannabidiol Inhibits Tumorigenesis in Cisplatin-Resistant Non-Small Cell Lung Cancer via TRPV2
9. Investigating the Susceptibility of Treatment-Resistant Oesophageal Tumours to Natural Killer Cell-Mediated Responses.
10. Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer
11. The DNA damage repair-related gene PKMYT1 is a potential biomarker in various malignancies
12. Exploitation of the vitamin A/retinoic acid axis depletes ALDH1-positive cancer stem cells and re-sensitises resistant non-small cell lung cancer cells to cisplatin
13. MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer
14. Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemness
15. Correction: Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
16. Correction to: Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer
17. Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC
18. When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?
19. BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC
20. Ajuba inhibits hepatocellular carcinoma cell growth via targeting of β-catenin and YAP signaling and is regulated by E3 ligase Hakai through neddylation
21. Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells
22. Correction: Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells
23. Development and characterisation of a panel of phosphatidylinositide 3-kinase – mammalian target of rapamycin inhibitor resistant lung cancer cell lines
24. In Vitro Anticancer Activity and in Vivo Biodistribution of Rhenium(I) Tricarbonyl Aqua Complexes
25. Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC
26. Impact and correlation of mutational load (ML) and specific mutations (mts) assessed by limited targeted profiling (LTP) with PD-L1 tumour expression (exp) in resected non-small cell lung carcinoma (NSCLC).
27. Bafilomycin A1 induces caspase-independent cell death in hepatocellular carcinoma cells via targeting of autophagy and MAPK pathways
28. Lung cancer stem cells: The root of resistance
29. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways
30. KAT5 (Tip60) is a potential therapeutic target in malignant pleural mesothelioma
31. VEGF-mediated cell survival in non-small-cell lung cancer: implications for epigenetic targeting of VEGF receptors as a therapeutic approach
32. Abstract A45: In depth molecular characterization of novel PI3K-mTOR inhibitor resistant NSCLC cell lines
33. Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer
34. The emerging role of microRNAs in resistance to lung cancer treatments
35. Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer
36. The role of DNA repair pathways in cisplatin resistant lung cancer
37. Strategic targeting of the PI3K–NFκB axis in cisplatin-resistant NSCLC
38. Markers of response to platinum-based chemotherapy in lung cancer
39. Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
40. The Role of Epigenetics in Resistance to Cisplatin Chemotherapy in Lung Cancer
41. PD2-1-6: Neuropilin-1 blockade inhibits hypoxia-induced Akt and MAPK phosphorylation and induces apoptosis of non-small cell lung cancer cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.